fda warning bpc-157 safety unapproved drug FDA's Overreach on Compounded Peptides Exciting news for peptides coming

Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for Health advisers begin meeting Thursday to review more than a half dozen peptides, unproven substances that have become a growing wellness trend despite little evidence they are safe or effective. FDA panel considers loosening regulations for some peptides AOL FDA panel reviews safety of unapproved peptide treatments

SKU: 9747815807 · From astonvaughan.co.uk